ライフサイエンスコーパス: clinical marker

1 us must be considered when CTpr is used as a clinical marker.

2 ated hemoglobin (HbA1c) remains the standard clinical marker.

3 is only modestly improved when combined with clinical markers.

4 he rich information contained in established clinical markers.

5 through the combination of both genetic and clinical markers.

6 stenosis was seen with increasing numbers of clinical markers.

7 were associated with longitudinal changes in clinical markers.

8 transmission better than microbiological or clinical markers.

9 graft loss beyond the level of contemporary clinical markers.

10 erentially dispersed' genes can be important clinical markers.

11 ict patients at risk of PMV and identify key clinical markers.

12 performance of MMP-7 was compared with other clinical markers.

13 ches involving the microbiome, radiomics and clinical markers.

14 disease and opens up possibilities for novel clinical markers.

15 of spinal cord atrophy and correlations with clinical markers.

16 tocol, which uses death certificate data and clinical markers.

17 treatment effects for anatomical regions and clinical markers.

18 nd differentially expressed genes in WAT and clinical markers.

19 markers provided greater power than standard clinical markers.

20 fulness of DNA methylation profiles as novel clinical markers.

21 with mortality in PDRD: (1) demographic and clinical markers (age, sex, body mass index and comorbid

22 Current clinical markers allow for more individualized risk stra

23 achieved higher predictive performance than clinical markers alone (AUC 0.78 vs. 0.66).

24 6.5-68.3), far higher than either genetic or clinical markers alone.

25 These findings validate HPV persistence as a clinical marker and endpoint.

26 Olfactory impairment may be an important clinical marker and predictor of these conditions and ma

27 Clinical marker and threshold selections were informed b

28 o this end, our tool analyzes and visualizes clinical markers and (epi-)genomics and transcriptomics

29 xamined: 1) the impact of this program on 55 clinical markers and 2) the effect of genetic predisposi

30 of 0.086 (P = 0.02) that was independent of clinical markers and adjuvant therapy.

31 can be identified early by a combination of clinical markers and etiologic factors.

32 ions between microbiome composition and host clinical markers and lifestyle factors, including host-m

33 Its relationship with standard clinical markers and long-term adverse events in chronic

34 The ALFSG index, a combination of clinical markers and measurements of the apoptosis bioma

35 cardiometabolic drug dosage, improvement in clinical markers and microbiome composition, supporting

36 of AKI through the combined use of available clinical markers and novel inflammatory, injury, and rep

37 ranscriptomic metric (AUC 0.80) outperformed clinical markers and plasma interleukin-6 for prospectiv

38 also prognostic and complemented established clinical markers and scores, significantly increasing th

39 er methylation was inversely correlated with clinical markers and symptoms associated with PTSD.

40 Objectives: We aim to identify clinical markers and therapeutic targets that inform the

41 ESR1, PGR, and ERBB2, which encode standard clinical markers and therapeutic targets.

42 lements, vitamins, hormones, selenoproteins, clinical markers, and perfluorinated compounds (PFCs), w

43 The diagnosis is difficult because clinical markers are often lacking, and symptoms usually

44 Periodontopathic clinical markers are poorly understood in the pediatric

45 Risk factors and clinical markers associated with ScGVHD remain largely u

46 Patients with primary care also had better clinical markers at diagnosis.

47 anisms that can be predicted by using simple clinical markers at the time of the first severe wheezin

48 wever, there is no global consensus on which clinical markers best define excessive bleeding or relia

49 proved discriminatory power than the current clinical marker CA19-9 for the discrimination of pancrea

50 true clinical significance of this important clinical marker can be clearly established.

51 Improvements in clinical markers closely correlated with a sustained red

52 is suggested in patients with lean NAFLD and clinical markers compatible with liver cirrhosis.

53 positive individuals show a deterioration in clinical markers consistent with the prodrome of PD.

54 cation based on the patient's microbiome and clinical markers, could optimize therapy.

55 ssential to study the natural progression of clinical markers during the prodromal stages of disease

56 Spirometry is routinely used as a clinical marker for assessing pulmonary allograft functi

57 breast cancer development, and as a primary clinical marker for breast cancer prognosis, has been we

58 Serum CPK may be a useful clinical marker for choline deficiency in humans.

59 We found no definitive clinical marker for differentiating class 1 and class 2

60 CT could potentially serve as a clinical marker for disease activity in pKCN; however, f

61 HBV e-antigen (HBeAg), a clinical marker for disease severity, is a soluble varia

62 termine the utility of this measurement as a clinical marker for future coronary events and long-term

63 ese findings suggest that PR status may be a clinical marker for genetic subgroups of meningioma and

64 As a clinical marker for heart failure, BNP is limited by con

65 Gamma-H2AX may be a useful clinical marker for monitoring the efficacy of aminoflav

66 nduced cutaneous tissue injury, represents a clinical marker for non-melanoma skin cancer (NMSC) risk

67 aging and has the potential to be used as a clinical marker for progression from mild cognitive impa

68 linked with mixed manic states and may be a clinical marker for recurrent dysphoric mania.

69 suicidal self-injury prior to treatment is a clinical marker for subsequent suicide attempts and shou

70 A BMI threshold of 26.4 may serve as a clinical marker for tailoring adalimumab therapy, highli

71 rmore, proepithelin may prove to be a useful clinical marker for the diagnosis of prostate tumors.

72 autoantibodies represent a highly promising clinical marker for the identification of SS.

73 short-term jaw pain fluctuations serve as a clinical marker for the impact status of TMD pain.

74 There are currently no robust clinical markers for assessing prognosis in patients wit

75 Identifying clinical markers for conversion from essential tremor to

76 igated the use of lipids from whole blood as clinical markers for docetaxel resistance in a small coh

77 s, particularly DME, may serve as accessible clinical markers for identifying individuals at elevated

78 We carried out a study to identify the clinical markers for patients at high risk of developing

79 tiators of metastasis and potentially useful clinical markers for patients with cancer.

80 illebrand disease (VWD) in the Molecular and Clinical Markers for the Diagnosis and Management of Typ

81 o 15-s-long) wake intrusions into sleep, are clinical markers for various sleep disorders.

82 xonomy of cancers and finding biological and clinical markers from microarray experiments is problema

83 andard equations relying on laboratory-based clinical markers has proven challenging and needs advanc

84 these molecular markers, along with standard clinical markers, has been developed and internally vali

85 The expression levels of the standard clinical markers HER2, estrogen receptor (ER), progester

86 evealed for the first time to correlate with clinical markers, highlighting the potential of calcific

87 DNA methylation is potentially an important clinical marker in cancer molecular diagnostics.

88 rodromal AD, and may be a potentially useful clinical marker in identifying MCI patients who are most

89 d, the five AAs were not as good as existing clinical markers in differentiating diabetic patients fr

90 T SUVRs did not correlate with impairment or clinical markers in HIV-positive participants.

91 and metabolome collectively associated with clinical markers in milder stage COPD.

92 global imaging metrics outperformed baseline clinical markers in predicting outcome, including SUVtot

93 Clinical markers in the peripheral blood guide the treat

94 Today's clinical markers include the total level of cholesterol

95 Main Outcomes and Measures: Assessment of clinical markers included the following standardized sca

96 uced mortality and blocks the development of clinical markers including hypotension and hypothermia.

97 e identification rates to selected objective clinical markers, including positive blood cultures, vas

98 after TOF repair and were related to adverse clinical markers, including ventricular dysfunction, exe

99 Clinical markers less invasive than biopsies, such as bl

100 The sensitivity of clinical markers (myoclonus) and tests historically cons

101 lity/anger during MDEs is a highly prevalent clinical marker of a more severe, chronic, and complex d

102 degraded by plasmin, is the most widely used clinical marker of activated blood coagulation.

103 of conditioned threat responses is a robust clinical marker of anxiety disorders.

104 ultimodal genomics data with a commonly used clinical marker of cardiovascular disease.

105 As a powerful clinical marker of circulatory collapse, the fast Fourie

106 commend any of these biomarkers as a routine clinical marker of CVD in children.

107 twisting rate (UTR) has been introduced as a clinical marker of diastolic function.

108 rculating MMP-9 level could be utilized as a clinical marker of disease activity.

109 later stages, and may represent an important clinical marker of disease progression.

110 ther validate spreading depolarizations as a clinical marker of early brain injury and establish a cl

111 Endothelial dysfunction is an established clinical marker of early coronary artery disease and has

112 make CRG-L2 an excellent candidate as a new clinical marker of HCC.

113 tively assessed plasma BNP as a quantitative clinical marker of heart failure severity in 107 consecu

114 re hypothesized as a requisite mechanism and clinical marker of infarct development.

115 The WBC count is a clinical marker of inflammation and a strong predictor o

116 ch characterizes sepsis even when the common clinical marker of inflammation, C-reactive protein, is

117 omes suggest RV infection to be an important clinical marker of instable preschool asthma.

118 Although rCBV is the clinical marker of interest, the Profile focused on the

119 physiologic reserve that may be an important clinical marker of longer surgical LOS.

120 Lower brainstem dysfunction, a clinical marker of neurologic injury not captured by the

121 ALT levels may be a useful clinical marker of reexposure.

122 We provide evidence that the clinical marker of resistance (delayed parasite clearanc

123 Microalbuminuria is an important clinical marker of several cardiovascular, metabolic, an

124 Since there is no reliable clinical marker of that response we recommend an indomet

125 Since there is no reliable clinical marker of that response, we recommend an indome

126 Thus, in obese patients, clinical markers of a prothrombotic state may indicate a

127 hma, baseline blood eosinophil levels and/or clinical markers of asthma severity predict response to

128 We identify potential clinical markers of axonal dysfunction to provide early

129 Clinical markers of calcium and bone metabolism were mea

130 or mean differences were computed regarding clinical markers of cardiovascular risk.

131 xtraction fraction, cerebral blood flow, and clinical markers of cerebrovascular impairment in adults

132 illness (AOR, 0.86 [95% CI, 0.50-1.49]), and clinical markers of complexity (AOR, 1.08 [95% CI, 0.61-

133 n source, then severity of illness, and then clinical markers of complexity).

134 Two of the clinical markers of disease activity measured in this st

135 Radiological and clinical markers of disease activity were significantly

136 ession of PD-1 and TIGIT was correlated with clinical markers of disease progression and declining pe

137 The data were assessed with respect to clinical markers of disease severity (Risk Adjusted Cong

138 teomics biomarker panel that correlates with clinical markers of disease severity and sudden cardiac

139 polymorphisms in the TNF-alpha promoter and clinical markers of disease severity in CBD.

140 toxic phenotype that correlated with various clinical markers of disease severity, whereas convalesce

141 structural, metabolic, neurodegenerative and clinical markers of disease, and some (p-tau217 and p-ta

142 ith objectively measured blood loss or other clinical markers of haemodynamic instability, and report

143 health, sleep quality, and food choices), 10 clinical markers of health (including cholesterol, blood

144 5%] vs 58 [98.3%]; P < .01), and identifying clinical markers of improvement (9 [20.9%] vs 52 [88.1%]

145 erizing Crohn disease activity compared with clinical markers of inflammation but, to the knowledge o

146 e response to innate signals, associate with clinical markers of inflammation, and shed light on over

147 n Crohn disease, but not with histologic and clinical markers of inflammation.

148 lectrographic seizures, were associated with clinical markers of injury severity but not functional o

149 5-MTP), whose levels strongly correlate with clinical markers of kidney disease.

150 the mechanisms and impact of blue spaces on clinical markers of mental health to support and inform

151 ociations with host multi-omics, immune, and clinical markers of microbiomes from four body sites in

152 and cortical deposition, associates with pre-clinical markers of neurodegeneration.

153 pheral or central neurologic function or any clinical markers of neurologic function in older people

154 f an association of vitamin B-12 status with clinical markers of neurologic function.

155 f VEGFR1 and VEGF-B correlate with edema and clinical markers of NP disease and therefore represent p

156 e cross-linking in proteins and peptides are clinical markers of oxidative stress, aging, and neurode

157 me was mortality and secondary outcomes were clinical markers of patient recovery, for example, multi

158 t of the correlation between the presence of clinical markers of periodontitis, such as pockets and c

159 over time exceeds that observed in standard clinical markers of photoreceptor structure - EZ width a

160 Ns also show differential relationships with clinical markers of poor prognosis and disease severity.

161 udy was to assess the prognostic accuracy of clinical markers of postpartum bleeding in predicting ma

162 resents the best data for long-term outcome, clinical markers of prognosis, and the results of random

163 ed, and their relationships with established clinical markers of progression were examined.

164 low dose, can exacerbate azotemia, increase clinical markers of renal disease, enhance glomerular im

165 and low body mass index represent predictive clinical markers of response.

166 x could be incorporated with the traditional clinical markers of risk to refine patient prognosis.

167 onflicts among gene expression, genetic, and clinical markers of risk.

168 Clinical markers of SCH severity assessed were not assoc

169 In this population, clinical markers of severe RA were present in a majority

170 w the genetics of severe depression by using clinical markers of severity including: age of onset, re

171 M patients and correlated exercise data with clinical markers of severity, computed tomography scans,

172 95[+/-2.3]%, P = 0.0002) and correlated with clinical markers of steroid responsiveness.

173 Clinical markers of surgical stress that were collected

174 MMPs correlated with clinical markers of tissue damage, further implicating d

175 ghly correlated with genomic alterations and clinical markers of tumor behavior.

176 AKs may be clinical markers of UV exposure and increased skin cance

177 A threshold effect in clinical markers (oxygenation, compliance and microCT) a

178 , making OSPP able to serve as an expandable clinical marker panel.

179 Premenstrual exacerbation may be a clinical marker predicting a more symptomatic and relaps

180 also lacked some significant improvements in clinical markers, primarily the lipid profile.

181 effect modelling to estimate annual rates of clinical marker progression stratified by disease subtyp

182 Clinical markers, protein, and GeneChip analysis were us

183 We identified sustained improvements in clinical markers related to cardiometabolic risk, inflam

184 ospitalizations with corresponding objective clinical markers remained stable or decreased.

185 chocardiographic scores with biochemical and clinical markers showed that only posttreatment 5-HIAA l

186 umors analyzed, much more widely than common clinical markers such as cell proliferation-related gene

187 ese demonstrated the increased expression of clinical markers such as Ki-67, prostate specific antige

188 Awareness of clinical markers, such as the ability to eat baked forms

189 ical perspective because these syndromes are clinical markers suggesting specific underlying patholog

190 he NRSF splice variant represents a specific clinical marker that could prove useful in detection of

191 CXCL9 is a novel clinical marker that identifies high-risk HLH independen

192 ativity before transplantation is a valuable clinical marker that identifies patients at risk for dev

193 automatically measured TID ratio is a useful clinical marker that is sensitive and highly specific fo

194 l echocardiography is a common and important clinical marker that is strongly associated with an incr

195 White blood cell count (WBC) is an important clinical marker that varies among different ethnic group

196 We aimed to identify MRI and clinical markers that differentiate non-acute MOG-antibo

197 ond clinical manifestation and commonly used clinical markers, there is ongoing research to identify

198 nal imaging and hemodynamic, functional, and clinical markers, three-dimensional cardiac motion impro

199 ence of BCL-6 gene mutations may be a useful clinical marker to determine whether reduction in immuno

200 opathology of the disease and is a potential clinical marker to help in treatment decisions after a f

201 together, activin is a novel candidate as a clinical marker to identify those acute pancreatitis pat

202 we computed the prognostic accuracy of each clinical marker to predict a composite outcome of matern

203 herefore, IP 5-HT levels may prove a helpful clinical marker to predict postoperative LD and clinical

204 ametric MRI, whole-mount histopathology, and clinical markers to evaluate the potential utility of (1

205 Assessment was performed for clinical markers using standardized scales for hyposmia,

206 Simple clinical markers, weighted according to prognostic impac

207 Five clinical markers were assessed: measured blood loss, pul

208 Data sets of clinical markers were simulated by use of differential e

209 he range of mouth opening variables were the clinical markers with the most significant associations